Product Information
BUPRENORPHINE 2 MG TABLET SL is a generic product labeled by Actavis Pharma, Inc., priced at $0.2629 per EA under NDC 00228315603. Its NADAC has been published 581 times since May 13, 2015.
Strength
2 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228315603
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Last Updated
6/17/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090819On Market Since
2/19/2015
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE 2 MG TABLET SL has been published 581 times since May 13, 2015, and over the history we have for it it has declined 81.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2629 per EA |
|---|---|
| All-time high | $1.4708 (Aug 12, 2015) |
| All-time low | $0.2629 (Jun 17, 2026) |
| 52-week high | $0.3346 |
| 52-week low | $0.2629 |
| Median price | $0.5364 |
| Average price | $0.6588 |
| Largest weekly change | +47.3% (Dec 21, 2016) |
| Weeks tracked | 581 |
| Tracking since | May 13, 2015 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUPRENORPHINE 2 MG TABLET SL?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 2 MG TABLET SL, manufactured by Actavis Pharma, Inc., is $0.2629 per EA (NDC 00228315603), effective Jun 24, 2026.
How has the price of BUPRENORPHINE 2 MG TABLET SL changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE 2 MG TABLET SL has declined 81.3%. It has been tracked across 581 weekly CMS publications since May 13, 2015.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 2 MG TABLET SL?
Since May 13, 2015, the NADAC for BUPRENORPHINE 2 MG TABLET SL has ranged from a low of $0.2629 (Jun 17, 2026) to a high of $1.4708 (Aug 12, 2015), with a median of $0.5364 per EA.
Are there cheaper alternatives to BUPRENORPHINE 2 MG TABLET SL?
5 NADAC-published products share the same active ingredient, strength, and dosage form as BUPRENORPHINE 2 MG TABLET SL, but none are currently priced below it.
Who manufactures BUPRENORPHINE 2 MG TABLET SL?
BUPRENORPHINE 2 MG TABLET SL (NDC 00228315603) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification